Penn Medicine received a $120 million gift from Catherine and Anthony Clifton
The Pavilion at the Hospital of the University of Pennsylvania will be renamed the Clifton Center for Medical Breakthroughs.
MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
Baylor College of Medicine9h
MAGE-4 promotes tumor progression by halting antitumor responses
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response ...
BioPharma Dive5h
Biogen inks royalty deal to gain funding for lupus drug R&D
The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...
BioSpace7h
Biogen Taps Royalty Pharma for $250M to Power Phase III Lupus Program
The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...
Royalty Pharma Announces R&D Funding Collaboration With Biogen
We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...